Canadian Investment Regulatory Organization Trade Resumption - CRDL

Canadian Investment Regulatory Organization Trade Resumption - CRDL

Trading resumes in:

Company: Cardiol Therapeutics Inc.

TSX Symbol: CRDL

All Issues: Yes

Resumption (ET): 8:00 AM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada..

SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions

Cision View original content: http://www.newswire.ca/en/releases/archive/October2025/20/c1710.html

News Provided by Canada Newswire via QuoteMedia

crdl:catsx:crdlbiotech investing
CRDL:CA
The Conversation (0)
Collage with hands holding shiny DNA molecule on blue background.

5 Biggest Biotechnology ETFs in 2026

The biotech sector has made significant strides in recent years, and the market's volatility can increase the appeal of biotech ETFs. Even with a good understanding of the system, no one can predict which treatment, device or therapy will give the biggest return, making biotech exchange-traded... Keep Reading...
Doctor holding stethoscope over digital document interface

Beyond the Lab: Top-Tier Clinical Validation in Biotech Investing

Nature Medicine’s “Eleven Clinical Trials That Will Shape Medicine in 2026” highlights studies poised to influence patient care. Among the oncology selections, BriaCell Therapeutics' (TSX:BCT,NASDAQ:BCTX) pivotal Phase 3 trial of Bria-IMT™ stands out as a rare entry. This feature underscores the... Keep Reading...
BriaCell Therapeutics Announces Closing of Offering

BriaCell Therapeutics Announces Closing of Offering

briacell therapeutics corp. (Nasdaq: BCTX, BCTXL, BCTXZ) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced the closing of its best-efforts offering of 1,449,300 common shares. Each common... Keep Reading...
BriaCell Presents Positive Clinical Data at ASCO 2026

BriaCell Presents Positive Clinical Data at ASCO 2026

Final Bria-IMT™ Phase 2 data show 55% >1 year and 27% >2-year survival in heavily pre-treated metastatic breast cancer (MBC) patients treated with Bria-IMT regimen selected for Phase 3TWiST analysis, which measures time without disease symptoms or significant treatment-related toxicity, showed... Keep Reading...
BriaCell Therapeutics Announces Pricing of Offering

BriaCell Therapeutics Announces Pricing of Offering

briacell therapeutics corp. (Nasdaq: BCTX, BCTXL, BCTXZ) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced the pricing of a best-efforts offering of 1,449,300 common shares. Each common... Keep Reading...
Double helix DNA with word "ETFs" and biotech stock tickers.

5 Small-cap Biotech ETFs to Watch in 2026

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, they give sector participants exposure to many biotech companies via one vehicle.ETFs are a popular choice as they allow investors to enter the market more safely... Keep Reading...

Latest News

Interactive Chart

Latest Press Releases

ILC Critical Minerals Ltd. Announces Extension of Private Placement

Strategic Demerger of North ǪLD Assets into Emerald Resources-backed entity

Golconda Gold Announces the Election of Paul Olmsted and James Colter Eadie to the Board of Directors

BriaCell Therapeutics Announces Closing of Offering

Related News

base metals investing

ILC Critical Minerals Ltd. Announces Extension of Private Placement

precious metals investing

Strategic Demerger of North ǪLD Assets into Emerald Resources-backed entity

gold investing

Ronald-Peter Stoeferle: Gold Price Hasn't Topped, on Track for US$8,900

graphite investing

ASX Graphite Stocks: 5 Biggest Companies of 2026

precious metals investing

Golconda Gold Announces the Election of Paul Olmsted and James Colter Eadie to the Board of Directors

gold investing

Chinese Regulator Delays Zijin Gold’s US$4 Billion Allied Gold Takeover

uranium investing

Cameco Boosts Cigar Lake Stake, Denison Makes Progress at Phoenix